Anti-CD20 therapy reduces lesion volume and activated microglia in rodent models of multiple sclerosis

Míreanna comhchosúla

• Anti-CD20 Therapy Reduces Microglial Activation and Lesion Volume in Focal Models of Pattern I and Pattern II Multiple Sclerosis
  de réir: Leppert, D, et al.
  Foilsithe / Cruthaithe: (2012)
• Anti-CD20 therapy reduces microglial activation and lesion volume in focal models of pattern I and pattern II multiple sclerosis
  de réir: Anthony, D, et al.
  Foilsithe / Cruthaithe: (2012)
• Anti-CD20 therapy down-regulates lesion formation and microglial activation in pattern I and pattern II rat models of multiple sclerosis
  de réir: Anthony, D, et al.
  Foilsithe / Cruthaithe: (2014)
• Anti-CD20 inhibits T cell-mediated pathology and microgliosis in the rat brain.
  de réir: Anthony, D, et al.
  Foilsithe / Cruthaithe: (2014)
• T cells and microglia as drivers of multiple sclerosis pathology.
  de réir: Friese, M, et al.
  Foilsithe / Cruthaithe: (2007)